Author

S. T. Tuomivaara

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2 Biochemistry· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 3 Assay:proteomics· 3 Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Research Focus:cell type annotation· 1 Approach:statistical model· 1

Frequent Co-Authors

A. P. Wiita· 3 shared C. Driessen· 2 shared I. D. Ferguson· 2 shared M. Hale· 2 shared Y.-H. T. Lin· 2 shared A. Lopez-Girona· 1 shared B. Hann· 1 shared B. P. Escobar· 1 shared

Activity by Year

2020-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 33 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersCancer Biology

A. P. Wiita

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

BiochemistryCommunications BiologyPeer-reviewedAug 29, 2024

SLAPSHOT reveals rapid dynamics of extracellularly exposed proteome in response to calcium-activated plasma membrane phospholipid scrambling

S. T. Tuomivaara, C. F. Teo, Y. N. Jan…·A. P. Wiita

SLAPSHOT labels extracellular proteins rapidly and specifically, revealing dynamic changes in the proteome during calcium-induced membrane scrambling.

DOI 10.1038/s42003-024-06729-x

humanproteomics

𝕏 PostBluesky

Cancer BiologyNature CommunicationsPeer-reviewedJul 15, 2022

Defining the cell surface proteomic landscape of multiple myeloma reveals immunotherapeutic strategies and biomarkers of drug resistance

I. D. Ferguson, B. P. Escobar, S. T. Tuomivaara…·A. P. Wiita

This study defines the myeloma cell surface proteome, identifies therapeutic targets and resistance biomarkers, and presents a miniaturized surface proteomics protocol.

DOI 10.1038/s41467-022-31810-6

humanproteomics

𝕏 PostBluesky

Cancer BiologybioRxivApr 21, 2020

Allosteric HSP70 inhibitors perturb mitochondrial proteostasis and overcome proteasome inhibitor resistance in multiple myeloma

I. D. Ferguson, Y.-H. T. Lin, C. Lam…·A. P. Wiita

This study identifies allosteric HSP70 inhibitors that overcome proteasome inhibitor resistance in multiple myeloma by targeting mitochondrial HSPA9 and disrupting mitoribosome stability.

DOI 10.1016/j.chembiol.2022.06.010

humanproteomics

𝕏 PostBluesky